JLE

Hématologie

MENU

Démarche diagnostique devant une neutropénie de l’adulte Volume 25, numéro 2, Mars-Avril 2019

  • [1] Dale D. How I manage children with neutropenia. Br J Haematol. 2017;178:351-363.
  • [2] Donadieu J. Recommandations pour le diagnostic et la prise en charge des patients ayant une neutropénie chronique. Registre français des déficits immunitaires héréditaires (CEREDIH). 20091-57.
  • [3] Stock W., Hoffman R. White blood cells 1: non-malignant disorders. Lancet. 2000;355:1351-1357.
  • [4] Moignet A., Donadieu J., Sicre de Fontbrune F., Lamy T. Les neutropénies chroniques et sévères de l’adulte. Hématologie. 2012;18:339-353.
  • [5] Schmutz N., Henry E., Jopling J., Christensen R.D. Expected ranges for blood neutrophil concentrations of neonates: the Manroe and Mouzonho charts revisited. J Perinat. 2008;28:275-281.
  • [6] Andres E., Weitten T., Federici L., Mecili M., Ciobanu E., Vogel T., Maloisel F. Neutropénie de l’adulte et du sujet âgé-diagnostic étiologique et prise en charge thérapeutique. Med Ther. 2008;14:314-321.
  • [7] Dale D, Wardlaw A, Lichtman M. Chapters 81, 84, 85. Hematology 1995 ; 815-24 : 844-58.
  • [8] Donadieu J. Les neutropénies chroniques de l’adulte : diagnostic et prise en charge. Med Ther. 2013;19:265-273.
  • [9] ANAES/HAS. Lecture critique de l’hémogramme : valeurs seuils à reconnaître comme probablement pathologiques et principales variations non pathologiques. Service des références médicales, 1997.
  • [10] Donadieu J., Maier-Redelsperger M., Haddad E. Neutropénies constitutionnelles : classification et prise en charge. Hématologie. 1995;6:489-493.
  • [11] Donadieu J., Beaupain B., Fenneteau O., Bellanné-Chantelot C. Congenital neutropenia in the area of genomics: classification, diagnosis and natural history. Br J Haematol. 2017;179:557-574.
  • [12] Dale D.C., Bolyard A.A., Schwinzer B.G., Pracht G., Bonilla M.A., Boxer L. The severe chronic neutropenia international registry: 10-year follow-up report. Support Cancer Ther. 2006;3:223-234.
  • [13] Andersohn F., Konzen C., Garbe E. Systematic review: agranulocytosis induced by non-chemotherapy drugs. Ann Int Med. 2007;146:657-665.
  • [14] Andres E., Maloisel F. Idiosyncratic drug-induced agranulocytosis or acute neutropenia. Curr Opin Hematol. 2008;15:15-21.
  • [15] Gibson C., Berliner N. How we evaluate and treat neutropenia in adults. Blood. 2014;124:1251-1258.
  • [16] Kamioner D., Aapro M., Bahadoor M.R.K., Jovenin N., Mayeur D. Prévention de la neutropénie fébrile. Horizons Hémato. 2014;4:59-60.
  • [17] Ram R., Ben-Bassat I., Shpilberg O., Polliack A., Raanani P. The late adverse events of rituximab therapy, rare but there! Leuk lymphoma. 2009;50:1083-1095.
  • [18] Yardley-Jones A., Anderson D., Parke D.V. The toxicity of benzene and its metabolism and molecular pathology in human risk assessment. Br J Ind Med. 1991;48:437-444.
  • [19] Kouamou E., Stépanian A., Khadra F., De prost D., Teillet F. Une étiologie rare d’anémie : la carence en cuivre. Ann Biol Clin. 2013;71:481-484.
  • [20] Laboratoire d’hématologie du CHU d’Angers. Diagnostic d’une neutropénie et d’une agranulocytose. http://www.hematocell.fr/index.php/enseignement-de-lhematologie-cellulaire.
  • [21] Dreyfus B., Dreyfus F. L’hématologie de Bernard Dreyfus. In: Flammarion Médecine Science, eds. Neutropénies. Paris: Flammarion Médecine Science; 1992.
  • [22] Marchand T., Pastoret C., Lamy T. Les leucémies à grands lymphocytes granuleux. Hématologie. 2015;21:303-310.
  • [23] Bareau B., Rey J., Hamidou M., Donadieu J., Morcet J., Reman O. Analysis of a french cohort of patients with large granular lymphocyte leukemia: a report on 229 cases. Haematologica. 2010;95:1534-1541.
  • [24] Akhtari M., Curtis B., Edmund K., Walker K. Autoimmune neutropenia in adults. Autoimmun Rev. 2009;9:62-66.
  • [25] Lalezari P., Jiang A.F., Yegen L., Santorineou M. Chronic autoimmune neutropenia due to anti-NA2 antibody. N Engl J Med. 1975;293:744-747.
  • [26] Shastri K.A., Logue G.L. Autoimmune neutropenia. Blood. 1993;81:1984-1995.
  • [27] Bux J., Behrens G., Jaeger G., Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood. 1998;91:181-186.
  • [28] Campion G., Maddison P.J., Goulding N., James I., Ahern M.J., Watt I. The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features and immunogenetic associations. Medicine (Baltimore). 1990;69:69-80.
  • [29] Burks E.J., Loughran T.P. Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood Rev. 2006;20:245-266.
  • [30] Bowman S.J. Hematological manifestations of rheumatoid arthritis. Scand J Rheumatol. 2002;31:251-259.
  • [31] Liu X., Loughran T.P. Jr. The spectrum of large granular lymphocyte leukemia and Felty's syndrome. Curr Opin Hematol. 2011;18:254-259.
  • [32] Starkebaum G. Chronic neutropenia associated with autoimmune disease. Semin Hematol. 2002;39:121-127.
  • [33] Hodgson K., Ferrer G., Pereira A., Moreno C., Montserrat E. Autoimmune cytopenia in chronic lymphocytic leukemia: diagnosis and treatment. Br J Haematol. 2011;154:14-22.
  • [34] Michel M., Chanet V., Dechartres A., Morin A.S., Piette J.C., Cirasino L. The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases. Blood. 2009;114:3167-3172.
  • [35] Coudurier M., Houot R., Geriniere L., Blandin S., Salles G., Lamy T. Tumeurs épithéliales thymiques, neutropénie et anémie hémolytique auto-immune. Rev Mal Resp. 2008;25:605-609.
  • [36] Wehr C., Kivioja T., Schmitt C., Ferry B., Witte T., Eren E. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111:77-85.
  • [37] Wang J., Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmunity. 2006;25:57-62.
  • [38] Madkaikar M., Mhatre S., Gupta M., Ghosh K. Advances in autoimmune lymphoproliferative syndromes. Eur J Haematol. 2011;87:1-9.
  • [39] Holzelova E., Vonarbourg C., Stolzenberg M.C., Arkwright P.D., Selz F., Prieur A.M. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med. 2004;351:1409-1418.
  • [40] Magerus-Chatinet A., Stolzenberg M.C., Loffredo M.S., Neven B., Schaffner C., Ducrot N. FAS-L, IL-10 and double negative CD4-CD8-TCRαβ+ T cells are reliable markers of autoimmune lymphoproliferative (ALPS) associated with FAS loss of function. Blood. 2009;113:3027-3030.
  • [41] Cartron J., Muller J.Y. Neutropénies néonatales immunes. Hématologie. 2003;9:379-387.
  • [42] Jonathan P.W., Haynes S., Stark G., Green F.A., Lucas G.F. Transfusion-related alloimmune neutropenia: an undescribed complication of blood transfusion. Lancet. 2002;360:1073-1074.
  • [43] Sicre de Fontbrune F., Moignet A., Beaupain B., Suarez F., Galicier L., Socié G. Severe chronic primary neutropenia in adults: report on a series of 108 patients. Blood. 2015;126:1643-1650.
  • [44] Papadaki H.A., Xylouri I., Coulocheri S., Kalmanti M., Kafatos A., Eliopoulos G.D. Prevalence of chronic idiopathic neutropenia of adults among an apparently healthy population living on the island of Crete. Ann Hematol. 1999;78:293-297.
  • [45] Reich D., Nalls M.A., Kao W.H. Reduced neutrophil count in people of african descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet. 2009;5:e1000360.
  • [46] Bain B.J. Ethnic and sex differences in the total and differential white cell count and platelet count. J Clin Pathol. 1996;49:664-666.
  • [47] Horwitz M.S. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood. 2007;109:1817-1824.
  • [48] Lange R.D. Cyclic hematopoiesis: human cyclic neutropenia. Exp Hematol. 1983;11:435-451.
  • [49] Newburger P.E., Pindyck T.N., Zhu Z., Bolyard A.A., Aprikyan A.A., Dale D.C. Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes. Pediatr Blood Cancer. 2010;55:314-317.
  • [50] Lekstrom-Himes J.A., Gallin J.I. Immunodeficiency diseases caused by defects in phagocytes. Adv Immunol. 2000;343:1703-1714.
  • [51] Horwitz M.S., Duan Z., Korkmaz B., Lee H.H., Mealiffe M.E., Salipante S.J. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood. 2007;109:1817-1824.
  • [52] Kawaia T., Malech H.L. WHIM syndrome: congenital immune deficiency disease. Curr Opin Hematol. 2009;16:20-26.
  • [53] Hahn C.N., Chong C.E., Carmichael C.L., Wilkins E.J., Brautigan P.J., Li X.C. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nature Genetics. 2011;43:1012-1017.